Cargando…
Repurposing of terconazole as an anti Trypanosoma cruzi agent
Trypanosoma cruzi is the causative agent of Chagas disease, a parasitic infection endemic in Latin America. Currently there are no effective treatments for the chronic phase of the disease, when most patients are diagnosed, therefore the development of new drugs is a priority area. Several triazoles...
Autores principales: | Reigada, Chantal, Sayé, Melisa, Valera-Vera, Edward, Miranda, Mariana R., Pereira, Claudio A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562323/ https://www.ncbi.nlm.nih.gov/pubmed/31211266 http://dx.doi.org/10.1016/j.heliyon.2019.e01947 |
Ejemplares similares
-
Identification of Trypanosoma cruzi Polyamine Transport Inhibitors by Computational Drug Repurposing
por: Reigada, Chantal, et al.
Publicado: (2019) -
Role of Trypanosoma cruzi nucleoside diphosphate kinase 1 in DNA damage responses
por: Reigada, Chantal, et al.
Publicado: (2020) -
Crystal violet structural analogues identified by in silico drug repositioning present anti-Trypanosoma cruzi activity through inhibition of proline transporter TcAAAP069
por: Sayé, Melisa, et al.
Publicado: (2020) -
Trypanocidal Effect of Isotretinoin through the Inhibition of Polyamine and Amino Acid Transporters in Trypanosoma cruzi
por: Reigada, Chantal, et al.
Publicado: (2017) -
Cationic Amino Acid Uptake Constitutes a Metabolic Regulation Mechanism and Occurs in the Flagellar Pocket of Trypanosoma cruzi
por: Miranda, Mariana R., et al.
Publicado: (2012)